|

18F-NOTA-ABY-030 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Vanderbilt-Ingram Cancer Center1

Indications

  • Radiotracer1
  • Metastatic Head and Neck Squamous Cell Carcinoma1
  • SCC - Squamous Cell Carcinoma1
  • Head and Neck Squamous Cell Carcinoma1
  • Cancer1

Nashville, Tennessee1 trial

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

Vanderbilt University Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.